R599
Pill imprint R599 has been identified as Etodolac 400 mg.
Etodolac is used in the treatment of osteoarthritis; pain; juvenile rheumatoid arthritis; rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Etodolac 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Etodolac Images
- Imprint:
-
R599
- Strength:
- 400 mg
- Color:
- Gray
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose
lactose monohydrate
magnesium stearate
maltodextrin
microcrystalline cellulose
polyethylene glycol
povidone
titanium dioxide
triacetin
ferric oxide black
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 00228-2599
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4468 | A S Medication Solutions LLC (repackager) |
| 55887-0808 | Diversified Healthcare Services Inc (repackager) |
| 66336-0878 | Dispensing Solutions Inc. (repackager) |
| 18837-0050 | Innoviant Pharmacy Inc (repackager) |
Note: Inactive ingredients may vary.
More Etodolac resources
- Etodolac
- Etodolac (Wolters Kluwer)
- Etodolac Extended-Release Tablets (Wolters Kluwer)
- etodolac (Cerner Multum)
- etodolac (Micromedex) - Includes Dosage Information
- Etodolac (AHFS DI)
- Etodolac (FDA)
- Etodolac Capsules (FDA)
- Etodolac Extended-Release Tablets (FDA)
- Etodolac (Wolters Kluwer)


